Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000038941 | SCV000062619 | likely benign | not specified | 2011-04-12 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000777974 | SCV000914078 | likely benign | Cardiomyopathy | 2018-09-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001785466 | SCV002027683 | uncertain significance | not provided | 2021-05-20 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this variant does not alter splicing; Reported in ClinVar as a likely benign variant (ClinVar Variant ID# 45719; Landrum et al., 2016) |
Labcorp Genetics |
RCV002054723 | SCV002373796 | likely benign | Lethal congenital glycogen storage disease of heart | 2024-02-04 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003996421 | SCV004842345 | likely benign | Hypertrophic cardiomyopathy | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004649065 | SCV005149141 | likely benign | Cardiovascular phenotype | 2024-05-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |